

Author: Zheng Hui-Wen Sun Ming Guo Lei Wang Jing-Jing Song Jie Li Jia-Qi Li Hong-Zhe Ning Ruo-Tong Yang Ze-Ning Fan Hai-Tao He Zhan-Long Liu Long-Ding
Publisher: MDPI
E-ISSN: 1999-4915|9|5|104-104
ISSN: 1999-4915
Source: Viruses, Vol.9, Iss.5, 2017-05, pp. : 104-104
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Data from EV-D68-infected patients demonstrate that pathological changes in the lower respiratory tract are principally characterized by severe respiratory illness in children and acute flaccid myelitis. However, lack of a suitable animal model for EV-D68 infection has limited the study on the pathogenesis of this critical pathogen, and the development of a vaccine. Ferrets have been widely used to evaluate respiratory virus infections. In the current study, we used EV-D68-infected ferrets as a potential animal to identify impersonal indices, involving clinical features and histopathological changes in the upper and lower respiratory tract (URT and LRT). The research results demonstrate that the EV-D68 virus leads to minimal clinical symptoms in ferrets. According to the viral load detection in the feces, nasal, and respiratory tracts, the infection and shedding of EV-D68 in the ferret model was confirmed, and these results were supported by the EV-D68 VP1 immunofluorescence confocal imaging with α2,6-linked sialic acid (SA) in lung tissues. Furthermore, we detected the inflammatory cytokine/chemokine expression level, which implied high expression levels of interleukin (IL)-1a, IL-8, IL-5, IL-12, IL-13, and IL-17a in the lungs. These data indicate that systemic observation of responses following infection with EV-D68 in ferrets could be used as a model for EV-D68 infection and pathogenesis.
Related content


By Wenzel Ulf Heine Josef Mengel Heidrun Erdmann Franziska Schaper Roland Heine Simon Daugschiess Arwid
Parasitology Research, Vol. 103, Iss. 1, 2008-06 ,pp. :


Telithromycin in lower respiratory tract infections
By Blasi F Cazzola M Tarsia P Aliberti S Baldessari C Valenti V
Future Microbiology, Vol. 1, Iss. 1, 2006-06 ,pp. :


By Schenk T. Huck B. Forster J. Berner R. Neumann-Haefelin D. Falcone V.
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 2, 2007-02 ,pp. :




Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals
By Kofteridis D. Papadakis J. Bouros D. Nikolaides P. Kioumis G. Levidiotou S. Maltezos E. Kastanakis S. Kartali S. Gikas A.
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 23, Iss. 12, 2004-12 ,pp. :